Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia

BACKGROUND: An 11q22 deletion is considered an independent factor predicting poor survival in chronic lymphocytic leukemia (CLL). METHODS: We searched the electronic CLL database for consecutive patients who presented to the M. D. Anderson Cancer Center Department of Leukemia from October 2003 to Ap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Tsimberidou, Apostolia-Maria, Tam, Constantine, Abruzzo, Lynne V., O'Brien, Susan, Wierda, William G., Lerner, Susan, Kantarjian, Hagop M., Keating, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404627/
https://ncbi.nlm.nih.gov/pubmed/19117034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23993
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars